Acute Kidney Injury from Intravitreal Anti-vascular Endothelial Growth Factor Drugs: A Systematic Review and Meta-analysis of Randomized Controlled Trials
ConclusionsIntravitreal anti-VEGF drugs were not associated with an acute kidney injury risk, regardless of which anti-VEGF drugs (aflibercept or ranibizumab) or retinal diseases (age-related macular degeneration, diabetic retinopathy/diabetic macular edema, or retinal vein occlusion) were involved.Systematic Review Protocol RegistrationPROSPERO CRD42021267854.
Source: BioDrugs - Category: Drugs & Pharmacology Source Type: research
More News: Age-Related Macular Degeneration (AMD) | Avastin | Diabetes | Drugs & Pharmacology | Endocrinology | Lucentis | PET Scan | Ranibizumab Injection | Study | Urology & Nephrology | Vitamin A